Collagen Induction Therapy in North Cyprus

The skin's repair mechanism follows a three-phase cascade, and collagen induction therapy triggers precisely this cascade in a controlled manner:

• Inflammation (0–48 hours): The micro-injury signal recruits platelets and macrophages. Growth factors are released: PDGF, TGF-β, VEGF, FGF, EGF.
• Proliferation (days 3–14): Fibroblasts divide and new Type III collagen synthesis begins; elastin and hyaluronic acid production also increase.
• Remodelling (2 weeks – 6 months): Type III collagen gradually matures into Type I collagen. This mature structure gives the skin its firm, elastic and youthful appearance. This is the window in which the true effect settles.

One important distinction: oral collagen supplementation (capsules, powders, drinks) and collagen induction therapy do not do the same job. Ingested collagen is broken down into amino acids by the digestive system and contributes broadly to the body's collagen synthesis — but it does not produce direct fibroblast activation in the facial skin. Collagen induction therapy is a local stimulation: the needle (or RF energy) delivers a direct signal to the target area and the fibroblast produces collagen there. These two approaches are not rivals; they operate through entirely different mechanisms.

When collagen induction therapy is mentioned, dozens of device names circulate in the market. Understanding the differences matters for patients, because price and recovery time vary significantly between modalities.

• Classic microneedling (Dermapen): A motorised pen with an adjustable needle depth of 0.25–2.5 mm. Mechanical collagen stimulation; recovery involves 24–48 hours of redness and mild flaking over 3–5 days. The broadest indication range and the most accessible cost. The first-line choice for skin texture, fine lines, superficial acne scars and stretch marks.
• RF microneedling (Morpheus8 / INFINI / Vivace-type): Radiofrequency energy is delivered through the needle tips. Thermal injury is added to the mechanical injury, reaching the deeper layers of the dermis. It provides stronger collagen contraction and skin tightening compared with classic microneedling. Recovery involves 3–7 days of redness, grid marks and peeling; social downtime must be planned accordingly. It is markedly superior to classic microneedling for skin laxity, lower-face and neck remodelling, and mid-life skin tightening.
• PRP combination: This is not a device in its own right; it is a biological layer added on top of microneedling or RF microneedling. Platelet-rich plasma (PRP) prepared by centrifuging your own blood is applied to the micro-channels that have been opened, and the growth factors amplify collagen stimulation. The detailed protocol is explained on the PRP page.
• Mesotherapy cocktail: A synthetic cocktail of hyaluronic acid, B-complex vitamins, amino acids and peptides. Applied during microneedling or by injection. A cost-effective option for younger skin showing early signs of dullness; further detail on the mesotherapy page.
• Exosome: Stem-cell-derived nano-vesicles with a high concentration of growth factors and signalling molecules. Clinical data are promising, but this is not a category fully approved by the FDA — regulatory bodies continue to evaluate exosome products. We frame it as a modern, evolving modality and address its honest limitations in a dedicated section below.
• PDO thread (collagen thread): Polydioxanone-based absorbable threads are placed beneath the skin via a specialist cannula. The initial effect is mechanical (a gentle lifting of the skin); over the following 6–12 months, fibrosis around the thread creates a second wave of collagen induction. It bridges the gap between surgery and microneedling for mild-to-moderate laxity.

There is no single correct answer: for a 28-year-old with young skin, a mesotherapy or classic microneedling protocol may be sufficient, while a 45-year-old with a softening jawline may be better served by RF microneedling combined with PDO threads. The right modality is determined individually for each patient at consultation.

Over the past few years, exosome therapy has become a prominent topic in medical aesthetics. Exosomes are small vesicles measuring 30–150 nanometres secreted by stem cells (typically derived from mesenchymal stem cells). Their contents include growth factors, signalling proteins, microRNA and lipids. The rationale is this: a more concentrated biological signal than PRP, with the advantage of being a manufactured product that does not require the patient's own blood.

We need to frame this honestly:

• Exosome therapy shows promising results in clinical use: positive reports exist in the literature for skin texture, acne scarring and hair loss.
• However, it is not a standard product category fully approved by the US FDA; regulatory authorities are still assessing exosome products. Clinical use is widespread in Europe and Asia.
• Product quality varies considerably between brands; the biological difference between a CE-certified product from an FDA-compliant laboratory and an unlabelled source is significant.
• It is not a "miracle"; like any other collagen induction modality, it delivers gradual, protocol-dependent results.

At Nis Clinic, we use exosome treatments only with products sourced from manufacturers who can provide source documentation and batch numbers. We do not sell exosome to patients as the outstanding single option; classic microneedling combined with PRP delivers equal or greater cost-effectiveness in most cases. If you choose exosome, we share in writing why, with which product, and with what expectations the treatment will be carried out.

Consultations are available in person at the clinic or online via WhatsApp or Zoom. The assessment covers four areas:

• Skin examination and Fitzpatrick type: Your skin phototype (I–VI) is determined. In darker skin types (IV, V, VI), the risk of post-inflammatory hyperpigmentation (PIH) increases substantially; the modality and session interval are chosen with this risk in mind. Where needed, a 3D skin analysis provides an objective map of dermal density, sebum levels and pigmentation.
• Target concern and priorities: Loss of firmness, fine lines, atrophic acne scarring, stretch marks, enlarged pores, dullness or a combination. The modality changes when the target changes.
• Expectations and social downtime tolerance: A patient with a wedding the following day and a patient who has planned three months ahead are not suitable for the same modality. RF microneedling leaves visible marks for 3–7 days; this must be factored into planning.
• Medical history: Pregnancy and breastfeeding, isotretinoin (Roaccutane) history, a tendency towards keloid scarring, active herpes, anticoagulant use, autoimmune skin conditions, uncontrolled diabetes and active cancer treatment are all assessed. For patients using isotretinoin or who have stopped within the past 6 months, treatment is not performed due to the risk of atypical scarring; we do not relax this safety rule.

After consultation, we share a written plan: which modality, how many sessions, how many weeks between sessions, the combination protocol, an indicative price and a realistic range of expected outcomes.

Duration varies by modality, but a typical collagen induction session proceeds as follows:

• Skin preparation: The face is cleansed of any make-up and cleaned with an antiseptic solution.
• Topical anaesthesia (30 minutes): A lidocaine/prilocaine cream is applied at effective thickness and left under occlusion. With well-administered anaesthesia, even RF microneedling remains tolerable.
• PRP preparation (if applicable, in parallel): While the anaesthesia takes effect, 15–20 ml of blood is drawn from the arm and prepared by calibrated centrifuge for 10–15 minutes in a CE-certified closed-system PRP kit.
• Device parameter setting: For classic microneedling, needle depth is adjusted by area (cheeks 1.0–1.5 mm, periorbital zone 0.5–0.75 mm, acne-scarred areas 1.5–2.0 mm). For RF microneedling devices, energy, depth and shot count are calibrated according to skin thickness.
• Application: A gliding gel is applied; the device advances in linear, cross-hatched and circular passes for uniform coverage. In classic microneedling, the target is "pinpoint bleeding" — the clinical sign that the correct depth has been reached. In RF, the practitioner monitors heat distribution between each shot.
• PRP / exosome application (if applicable): Immediately after the device passes are complete, the biological agent is infused into the open micro-channels; part of it is supplemented by punctate injection via a 30-gauge needle.
• Soothing: A hyaluronic acid-based mask is applied to the skin for 10–15 minutes; a cold compress settles the inflammatory response.

A single-modality facial session takes 45–60 minutes; an RF microneedling or PRP/exosome combination session takes 60–75 minutes. The patient leaves the clinic after treatment and returns to daily life with no restrictions beyond avoiding make-up and sun exposure for the first 24 hours.

Collagen induction therapy does not follow a single prescription; it is applied in varying protocols according to skin condition. Some combinations we commonly use:

• General skin renewal (age 30–40, mild ageing): Classic microneedling + PRP, 4 sessions, 4 weeks apart. 1–2 booster sessions per year.
• Atrophic acne scarring (rolling/boxcar): Classic microneedling + PRP, 5–6 sessions, 6 weeks apart. TCA CROSS is added for ice-pick scars.
• Skin laxity (age 40–55): RF microneedling, 3 sessions, 4–6 weeks apart. Where jawline laxity is marked, combined with PDO threads.
• New stretch marks (striae rubrae): Classic microneedling + PRP, 4–5 sessions, 6 weeks apart.
• Established stretch marks (striae albae): Classic microneedling + PRP, 5–6 sessions, 6–8 weeks apart.
• Mild laxity + skin texture (age 35–45): RF microneedling 2 sessions + classic microneedling + PRP maintenance 2 sessions.

These examples are starting templates used at consultation, not fixed prescriptions. The skin's response is assessed after the 2nd session; the modality or number of sessions may be revised accordingly.

The effects of collagen induction therapy are not immediate; it is a biological treatment, and the collagen maturation period spans 3–6 months. Here is a realistic timeline:

• 0–48 hours: Redness, mild swelling, a warm sensation (varies by modality).
• 3–7 days: Light flaking (classic microneedling) or grid marks and peeling (RF microneedling).
• 2 weeks: The skin brightens slightly and moisture retention improves — this is mechanical hydration, not yet the collagen response.
• 4–6 weeks: The first visible tissue improvement begins. With acne scarring, depth reduction starts in this window.
• 2–3 months: The collagen response becomes more apparent; firmness and tissue quality become noticeable.
• 3–6 months: Mature effect settles — Type III collagen converts to Type I collagen. This is the true evaluation window for the treatment.
• 6–12 months: The effect gradually softens; for this reason, 1–2 booster sessions per year are recommended.

Aftercare rules during the recovery period:

• No washing for 24 hours, then lukewarm water and a gentle, pH-balanced cleanser. No mechanical scrubbing, brushes or exfoliating pads.
• Sun protection for 14 days — SPF 50+ mineral-based (zinc oxide, titanium dioxide). In the Northern Cyprus sun, continue for 30 days. Sun exposure is the primary trigger for PIH.
• No active ingredients for 5–7 days: Retinoids, AHA/BHA acids and vitamin C serum are paused.
• Intensive moisturising: Hyaluronic acid serum and ceramide-panthenol barrier-repair products.
• Exercise, sauna, steam room — postponed for the first 48 hours; swimming pools and the sea — postponed for the first 72 hours.

Mild redness and light crusting are expected findings. Redness persisting beyond 5 days, pronounced swelling, pus, pain or fever suggest infection and require a clinic review. Our clinic team is available via WhatsApp for 72 hours after each session.

• Age 25–30, preventive approach: No static ageing signs yet; younger patients wanting to preserve skin vitality and support collagen production. A mesotherapy or light classic microneedling protocol is generally recommended.
• Age 30–45, classic cosmetic candidate: The largest group — fine lines, loss of skin texture, enlarged pores, dullness. Effective response with classic microneedling + PRP or RF microneedling combinations.
• Age 40–55, laxity-focused patients: Softened jawline, mild-to-moderate laxity in the lower face and neck. RF microneedling and PDO thread combination is the strongest indication.
• Atrophic acne scarring (rolling, boxcar): Classic microneedling + PRP as first-line treatment. TCA CROSS is added for ice-pick scars; the algorithm is detailed on the dermaroller page and the acne treatment page.
• Stretch marks (striae): Better response in red (new) stretch marks; moderate response in white (established) marks. PRP combination is recommended.
• Striae gravidarum (post-pregnancy): Microneedling + PRP can begin after breastfeeding has ended.
• Male patients: Male skin is approximately 25% thicker; deeper needle depths and slightly more frequent sessions may be required. Protocols targeting areas of beard thinning or scalp reduction are assessed separately.
• Mature post-surgical scarring (6+ months): Microneedling can produce a significant improvement in scar tissue quality.

Situations where collagen induction therapy is not appropriate:

• Under-eye bags caused by fat herniation: PRP or microneedling is not the solution here — a lower blepharoplasty (eyelid surgery) assessment is needed.
• Moderate-to-severe facial laxity: RF microneedling helps but cannot replace surgery alone; a facelift consultation should be discussed.
• Pigmentation predominantly melanin-related: Collagen induction therapy is not the first-line choice for pigmentation; pigmentation treatment protocols take priority.

In the following situations, collagen induction therapy is not performed or requires special assessment:

• Active skin infection in the treatment area: herpes simplex activation, acne abscess, impetigo, folliculitis — postponed until resolution. In patients with a history of recurrent herpes, antiviral prophylaxis (valaciclovir) may be started 48 hours before treatment.
• Active inflammatory acne: Acne must be brought under control before scar treatment. Microneedling over active lesions spreads infection.
• Isotretinoin (Roaccutane) use: Microneedling and RF microneedling are not performed during active treatment or within 6 months of stopping. The rationale: the drug's effect on sebaceous glands and wound healing increases the risk of atypical scarring (hypertrophic, keloid). Some current studies suggest the wait may safely be reduced to 1–3 months, but the international consensus continues to recommend 6 months, and Nis Clinic maintains this safety margin.
• Keloid and hypertrophic scarring tendency: Microneedling may trigger new keloid formation in susceptible individuals; treatment is not performed.
• Pregnancy and breastfeeding: Deferred due to insufficient clinical data. Striae gravidarum treatment begins after breastfeeding has ended.
• Cancer treatment and immunosuppressive therapy: Patients receiving active chemotherapy or radiotherapy are excluded; oncologist approval is mandatory.
• Active autoimmune skin conditions: Scleroderma, active vitiligo, active lupus, pustular psoriasis — require specialist assessment.
• Uncontrolled diabetes: Wound healing is delayed; treatment is not performed until glycaemic control is achieved.
• Anticoagulant therapy: The decision to pause medication is taken together with the treating physician; aspirin/NSAIDs may be stopped 7 days before with physician approval, but prescribed anticoagulants cannot always be safely discontinued.
• Clotting disorders: Haemophilia, Von Willebrand disease, thrombocytopaenia — PRP combination is not performed.
• Under 18 for cosmetic purposes.
• Suspected body dysmorphic disorder: Patients who persistently request more procedures and are never satisfied with any result — a psychological assessment is recommended.

Darker skin type (Fitzpatrick IV–VI) — special protocol: PIH risk is elevated. Conservative depth (rarely exceeding 1.0 mm in classic microneedling), 8 weeks between sessions, 2–4 weeks of pre-treatment skin preparation with 2–4% hydroquinone or tranexamic acid, SPF 50+ mineral sun protection for 30 days post-treatment, and a pilot patch test at the first session. Fitzpatrick IV is common among the patient profile arriving in Northern Cyprus from Türkiye and the Middle East; a conservative strategy is our standard approach for this group.

Saying "no" during candidacy assessment is not lost business for us — it is a necessary decision in the interest of genuine treatment outcomes and patient safety.

• Calibrated device for each modality: For classic microneedling, a motorised Dermapen-type automatic pen; single-use cartridge for each patient with a documented batch number. For RF microneedling, a calibrated device with annual training updates for the practitioner on each device.
• Depth and energy matched to indication: Parameters are set area by area following examination. Within a single session, the forehead, cheeks, nasal sidewalls and periorbital zone may each be treated at different settings.
• PRP and exosome add-on standard: CE-certified closed-system kit, calibrated centrifuge, batch number tracking. For exosome products: manufacturer documentation and source transparency.
• Topical anaesthesia as standard: 30 minutes of occluded lidocaine/prilocaine at every session. Treatment is not performed without anaesthesia.
• Dr. Meyzin's supervision: The treatment is carried out under the protocol of and in the direct supervision of Op. Dr. İbrahim Meyzin. A background in plastic surgery — facial anatomy, vascular mapping, wound healing dynamics — is a decisive advantage for depth selection, safety margins in sensitive areas and modality decisions.
• Post-session follow-up: The clinic team is available via WhatsApp for 72 hours; a clinical review at 2 weeks; the next session planned at 4–6 weeks.

We do not adopt the marketing language that presents a specific device as a "miracle" solution on its own. Morpheus8, PDO threads and exosome are all good tools; but none of them is the right solution for every patient, alone.

Our selection criteria are as follows:

• Skin age and quality: RF microneedling is excessive for fine lines in a 28-year-old; classic microneedling is sufficient.
• Presence of skin laxity: Classic microneedling is insufficient for mild laxity in a 45-year-old; RF microneedling or PDO thread combination is more appropriate.
• Skin type (Fitzpatrick): In darker skin, conservative classic microneedling is preferred over aggressive RF.
• Social downtime tolerance: A patient with a wedding the following week is offered gentler modalities, not RF microneedling.
• Budget: Exosome or RF microneedling is notably more expensive than classic microneedling + PRP; the highest-priced modality is not "best" for every patient.

At consultation, we present two or three modality options side by side with their recovery times and costs; the decision is made together. "We only offer this one device" or "we recommend the most expensive package" are not part of our approach.

Nis Clinic collagen induction therapy prices are set according to modality and session package; we do not negotiate per unit. The standard remains the same; a package discount does not mean a compromise in that standard.

Approximate price ranges (Nis Clinic — 2026 reference):

These are indicative prices — a reference framework. The confirmed price for each patient is given after skin analysis and modality selection. All prices are finalised after consultation; there are no hidden charges. The Dermapen cartridge, PRP kit and any exosome ampoule used are shared with a batch-numbered document.

Collagen induction therapy is a day-treatment procedure and does not require a medical tourism package; however, for patients combining treatment with a holiday, having the first session at our clinic and remaining sessions at a clinic in your home country is possible. Do not expect to see the full difference after a single session — the protocol operates on a biological timeline.